Femasys Inc. (FEMY)

NCM – Real Time Price. Currency in USD

0.48

-0.02 (-3.15%)

At close: Mar 27, 2026, 4:00 PM EDT

0.45

-0.03 (-6.72%)

After-hours: Mar 27, 2026, 7:57 PM EDT

About the company

Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination solution; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; FemCath, a cornual balloon catheter for selective fallopian tube evaluation; and FemChec, a controlled contrast-generating device for fallopian tube diagnosis. It also develops FemBloc, a non-surgical permanent birth control solution. The company offers its products to reproductive endocrinologists, gynecological physicians, related healthcare professionals, and women’s healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.

Key Executives

Name	Position
Dr. James H. Liu M.D.	Chief Medical Officer
Dr. Jeffrey Marcus M.D., M.S.	Chief Medical Advisor
Mr. Dov Elefant	Chief Financial Officer
Ms. Christine Thomas	Senior VP of Regulatory & Clinical Affairs
Ms. Kathy Lee-Sepsick M.B.A.	Founder, President, CEO & Director
Ms. Mary An Merchant J.D., Ph.D.	Vice President of Counsel & Intellectual Property